Paxos Medical Inc.

Maple Plain, MN · Founded 2023 · Medtech · Private

minimally invasive neural stimulation implant for on-demand bladder control

Claim this profile

Follows are private to you and power your alerts

Updated · paxosmedical.com

Sector
Medtech
Headquarters
Maple Plain, MN
Founded
2023
Latest Form D
$2.1M, May 2026
Total capital
$2.1M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$2.1M
1 Form D · last May 2026
5 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history, newest first
DateEventSourceAmount
Private capital raisedForm D · SEC$2,073,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2292SINGLETO2 THERAPEUTICS LLC——
2293NANODIAGNOSTIC TECHNOLOGY, LLC——
2294POPNEURON LLC——
2295Paxos Medical Inc.—$2.1M
2296COBIO DIAGNOSTICS INC.——
2297COHI GROUP L.L.C.——
2298PULVINAR NEURO LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Jeffrey ErbDirector
  • Matthew FraserDirector

Patents

No patents are on record under this company's name.

USPTO publishes applications about 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won't match.

Checked: USPTO granted patents and published applications

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.